Skin & Subcutaneous Tissue

Venous stasis ulcers: management

Clinical Overview and When to Suspect Venous Stasis Ulcers

— Age >55, female sex, obesity (BMI >30), multiparity

— Prior DVT or superficial thrombophlebitis (post-thrombotic syndrome)

— Prolonged standing occupations (nurses, teachers, factory workers)

— Family history of varicose veins, prior leg trauma or orthopedic surgery

— Heart failure, sedentary lifestyle, immobility

— Recurrent or non-healing ulcer over the medial malleolus / gaiter area (between knee and ankle)

— Background of lipodermatosclerosis, hyperpigmentation, or varicose veins

— Edema worse with dependency, improves with elevation overnight

— Mild aching, heaviness, pruritus — not the severe rest pain of arterial disease

— Ankle-brachial index (ABI) <0.8 → caution with compression

— Sudden enlargement, rolled edges, or atypical site → biopsy for Marjolin ulcer (SCC in chronic wound)

— Fever, expanding erythema, purulent drainage → cellulitis vs deep infection

Board pearl: A chronic, shallow, irregularly bordered ulcer at the medial malleolus with surrounding hemosiderin staining and edema is venous until proven otherwise — order an ABI before compression, not a CT angiogram.

Step 3 management: VSUs are an outpatient, primary-care–owned problem; success depends on long-term compression adherence, weight loss, and treating reflux — refer to vascular only if not healed by 4–6 weeks of optimal therapy or if ABI is abnormal.

Venous stasis ulcers (VSUs) are the most common cause of chronic lower extremity ulceration, accounting for ~70–80% of leg ulcers in US ambulatory practice

Pathophysiology: chronic venous hypertension from valvular incompetence (superficial, deep, or perforator), prior DVT, or calf muscle pump failure → capillary leak, fibrin cuffs, leukocyte trapping, and tissue hypoxia → skin breakdown

Epidemiology and risk factors to flag on the stem:

When to suspect on Step 3:

Ambulatory red flags that change management:

Presentation Patterns and Key History

— Middle-aged or older woman, BMI 32, varicose veins, "shallow weepy sore above the ankle for 3 months"

— Reports dull aching, heaviness, and itching in the leg, worse at end of day and after prolonged standing

— Symptoms improve overnight or with leg elevation — a hallmark of venous, not arterial, disease

— May describe prior episodes of "phlebitis," DVT after a hip replacement, or pregnancy-related leg swelling

— Slow onset, often after minor trauma (bumping the leg on furniture)

— Exudate is serous to serosanguinous, frequently soaking dressings or socks

— Itching and weeping precede frank ulceration in many cases

— Pain is mild to moderate, relieved by elevation — severe pain or pain worsened by elevation suggests arterial disease or infection

— Occupation and hours of standing/sitting

— Mobility, gait, use of assistive devices

— Adherence history with prior compression (most "failed therapy" is non-adherence)

— Smoking, diabetes, prior radiation, autoimmune disease

— Sleep position, ability to elevate legs at home, ability to don stockings (hand strength, arthritis, obesity)

— Calcium channel blockers, NSAIDs, gabapentin, pioglitazone → worsen edema

— Anticoagulants → bleeding risk under compression

— Diuretics — often misused as primary edema therapy in venous disease

Key distinction: Venous pain = dull, heavy, relieved by elevation; arterial pain = sharp, claudication or rest pain, worse with elevation, relieved by dependency; neuropathic pain = burning, stocking distribution, present regardless of position.

Board pearl: Always ask about prior DVT and pregnancies — post-thrombotic syndrome is the dominant driver of recurrent VSU and predicts poor healing without aggressive compression.

Classic patient on the vignette:

Wound characteristics by history:

Functional and social history to capture (Step 3 loves these):

Medication history that matters:

Physical Exam Findings and Hemodynamic Assessment

— Shallow, irregular ulcer with sloping edges and red granulating base

— Surrounding hemosiderin (brown) staining, atrophie blanche (porcelain-white scars), and lipodermatosclerosis (inverted champagne bottle leg)

— Stasis dermatitis: erythematous, scaly, weeping plaques — often misdiagnosed and treated as cellulitis

— Varicose veins, telangiectasias (corona phlebectatica around the ankle)

— Pitting edema improving with elevation

— Brawny, non-pitting edema indicates chronic disease and lymphedema overlap

— Palpate dorsalis pedis and posterior tibial pulses

— Capillary refill, temperature, hair distribution

— Ankle-brachial index (ABI) in every patient before initiating compression

— ABI >0.8 → full compression safe (30–40 mmHg)

— ABI 0.5–0.8 → modified/reduced compression (23–30 mmHg)

— ABI <0.5 → no compression, vascular surgery referral

— ABI >1.3 → non-compressible (calcified) vessels in DM/CKD → toe-brachial index

Step 3 management: Document ABI before the first compression order — applying high compression to a patient with undiagnosed PAD is a tested patient-safety error and a malpractice trigger.

Board pearl: Bilateral stasis dermatitis is commonly misdiagnosed as bilateral cellulitis — true cellulitis is almost always unilateral; treating "bilateral cellulitis" with antibiotics is a classic Step 3 wrong-answer trap.

Inspection of the gaiter region (medial malleolus → mid-calf):

Edema assessment:

Arterial exam — mandatory before compression:

Neurologic exam: monofilament testing in diabetics to rule out neuropathic contribution

Wound assessment to document each visit: size (length × width × depth), tunneling, undermining, exudate, odor, surrounding tissue

Diagnostic Workup — Initial Labs, Imaging, and Bedside Studies

— ABI (handheld Doppler + sphygmomanometer): essential before compression

— Toe-brachial index (TBI) if ABI >1.3 or non-compressible vessels (diabetes, ESRD)

— Wound measurement and photography for longitudinal tracking

— CBC — anemia impairs healing

— HbA1c and fasting glucose — undiagnosed diabetes is common

— Albumin/prealbumin — nutritional optimization if <3.0 g/dL

— BMP — renal function before NSAIDs, diuretics, contrast

— Hypercoagulability workup only if recurrent VTE, young age, or family history

— Venous duplex ultrasound is the workhorse — assesses reflux (>0.5 sec) and obstruction in superficial, deep, perforator systems

— Order with patient standing for accurate reflux measurement

— Indications: all non-healing ulcers, recurrent ulcers, planning intervention

— Do not routinely culture chronic wounds — all are colonized

— Culture only if clinical signs of infection: increasing pain, erythema beyond wound edge, purulence, fever, delayed healing despite optimal care

— Use tissue biopsy or curettage, not superficial swab, when culture indicated

Board pearl: A swab of any chronic wound will grow Staph and Pseudomonas — treating colonization with antibiotics breeds resistance and does not improve healing.

Step 3 management: Order standing venous duplex at the initial visit for any new or recurrent VSU — it identifies treatable reflux, which when ablated improves healing and reduces recurrence (EVRA trial).

VSU diagnosis is primarily clinical; testing exists to (1) confirm hemodynamics, (2) exclude mimics, (3) optimize healing

Bedside / office studies — first line:

Labs to consider in the ambulatory workup:

Imaging:

Wound cultures:

Diagnostic Workup — Advanced and Confirmatory Studies

— Reflux defined as retrograde flow >500 ms in superficial/deep veins, >350 ms in perforators

— Identifies great saphenous, small saphenous, and perforator incompetence amenable to ablation

— Also rules out acute or chronic DVT contributing to post-thrombotic syndrome

— CT or MR venography: suspected iliocaval obstruction (May-Thurner, prior pelvic surgery/radiation, persistent edema despite good superficial therapy)

— Intravascular ultrasound (IVUS) during venography: gold standard for iliac vein stenosis

— Plethysmography: quantifies calf pump function; used in research and select clinics

— Ulcer present >3 months without improvement on optimal therapy

— Atypical features: raised/rolled edges, exuberant granulation, location outside gaiter area, severe pain disproportionate to appearance

— Biopsy from the edge (not center) — rule out squamous cell carcinoma (Marjolin ulcer), basal cell, melanoma, vasculitis, pyoderma gangrenosum

— ANA, ANCA, cryoglobulins, RF if vasculitic features or systemic symptoms

— Hemoglobin electrophoresis in patients of African descent with malleolar ulcers (sickle cell)

— Anti-phospholipid antibodies if livedo, prior thromboses

— Hypercoagulable panel in young patients with recurrent VTE

Key distinction: Reflux >500 ms on duplex = candidate for endovenous ablation; obstruction on CT venography = candidate for iliac stenting — both improve VSU healing.

Board pearl: Any leg ulcer not healed after 3 months of optimal compression deserves a punch biopsy of the edge to exclude SCC — Marjolin ulcer is the dreaded miss.

Venous duplex ultrasound details (the confirmatory test for venous reflux):

When to escalate imaging:

Biopsy indications — do not miss malignancy:

Additional workup when mimics suspected:

Risk Stratification and First-Line Management Logic

— Compression (the cornerstone)

— Cleansing and wound bed preparation

— Correction of underlying reflux/obstruction

— Comorbidity optimization (weight, diabetes, nutrition, edema medications)

— Multilayer compression bandaging (e.g., Profore 4-layer) providing 35–40 mmHg at the ankle — gold standard for active ulcers

— Alternative: short-stretch bandages or Unna boot (zinc oxide–impregnated)

— Once healed: knee-high graduated compression stockings 30–40 mmHg, lifetime, replaced every 6 months

— Leg elevation above heart level for ≥30 min, 3–4×/day

— Exercise — calf-strengthening and walking to augment muscle pump

— Weight loss if BMI >30 (every 5 kg reduces venous pressure measurably)

— Tissue debridement (sharp, enzymatic, autolytic with hydrogels)

— Infection/inflammation control

— Moisture balance — moist wound healing with appropriate dressing

— Edge advancement

— Low exudate → hydrocolloid, hydrogel

— Moderate → foam

— High → alginate or superabsorbent

— Avoid wet-to-dry gauze (damages granulation tissue)

Step 3 management: The single most evidence-supported intervention is graduated compression — without it, no dressing, antibiotic, or supplement will heal a VSU; with it, ~70% heal by 6 months.

CCS pearl: At each follow-up, order: wound measurement, compression reapplication, weight, BP, blood glucose, and patient education on stocking adherence — schedule every 1–2 weeks until healed.

Core management framework — the "4 C's" of VSU care:

CEAP classification helps stratify (C0–C6; active ulcer = C6, healed = C5)

First-line therapy — start at the initial visit:

Wound bed preparation (TIME framework):

Dressing selection by exudate:

Pharmacotherapy — First-Line and Adjunctive Drugs

— Reduces blood viscosity, improves microcirculation

— Cochrane review: improves healing both with and without compression

— Side effects: GI upset (take with food), headache, dizziness

— Avoid with recent cerebral/retinal hemorrhage

— Used in Europe; available as supplement in US

— Modest healing benefit as adjunct to compression

— Acetaminophen first line

— Avoid chronic NSAIDs (edema, renal effects, GI bleed risk)

— Topical lidocaine for dressing changes

— Topical antibiotics (neomycin, bacitracin) → high rate of contact dermatitis, do not improve healing

— Hydrogen peroxide, povidone-iodine, Dakin's → cytotoxic to fibroblasts

— Silver dressings: only for clinically infected wounds, short course

— Cover Staph/Strep: cephalexin 500 mg QID or dicloxacillin

— MRSA risk → TMP-SMX or doxycycline

— Duration: 7 days, reassess

Board pearl: Pentoxifylline + compression is the highest-yield pharmacologic answer on Step 3 for a non-healing VSU after adequate compression alone.

Key distinction: Stasis dermatitis (treat with topical steroid + emollient + compression) ≠ cellulitis (treat with systemic antibiotics) — misdiagnosis leads to repeated antibiotic courses and resistance.

No pharmacotherapy substitutes for compression — drugs are adjuncts

Pentoxifylline 400 mg PO TID — strongest adjunct evidence:

Micronized purified flavonoid fraction (MPFF, diosmin/hesperidin):

Aspirin 300 mg/day: limited but suggestive evidence for faster healing — consider if no contraindication

Pain control:

Topical agents — what to avoid:

Systemic antibiotics: only for clinical infection (cellulitis, sepsis), not colonization

Diuretics: only if true volume overload (CHF) — not a primary VSU therapy

Stasis dermatitis flare: medium-potency topical steroid (triamcinolone 0.1%) ×1–2 weeks; avoid sensitizers

Procedural and Interventional Management

— Early endovenous ablation within 2 weeks of starting compression → faster healing (56 vs 82 days) and lower recurrence vs deferred ablation

— Refer to vascular surgery early, not after months of compression failure

— Radiofrequency ablation (RFA) of great/small saphenous vein

— Endovenous laser ablation (EVLA)

— Mechanochemical ablation (MOCA, ClariVein)

— Cyanoacrylate glue (VenaSeal) — non-thermal, no tumescent anesthesia

— All outpatient, local anesthesia, return to work next day

— Add to compression for ulcers >1 month unhealed or >5 cm

— Improve healing rates but expensive — verify coverage

Step 3 management: For a patient with VSU and saphenous reflux on duplex, refer for early endovenous ablation alongside compression — do not wait for "failure of conservative therapy."

CCS pearl: Order venous duplex → consult vascular surgery → continue compression → schedule wound check in 1–2 weeks.

Indication for procedural therapy: superficial venous reflux on duplex + active or healed VSU (CEAP C5–C6)

EVRA trial (NEJM 2018) changed practice:

Endovenous ablation options:

Ultrasound-guided foam sclerotherapy: tributaries, perforators, tortuous veins

Surgical ligation/stripping: largely replaced by endovenous methods but still used for select anatomy

Iliac vein stenting: for non-thrombotic (May-Thurner) or post-thrombotic iliac obstruction confirmed on CT venography/IVUS — improves healing in refractory VSU

Skin substitutes / bioengineered grafts (Apligraf, Dermagraft):

Split-thickness skin grafting: large, clean, granulating wounds after reflux corrected

Negative pressure wound therapy (NPWT): select large/deep wounds, bridge to grafting; not standard first-line for VSU

Adjunctive: hyperbaric oxygen — limited evidence in VSU (more for diabetic foot ulcers)

Special Populations — Elderly and Renal/Hepatic Impairment

— Functional barriers to compression: arthritis, weak grip, obesity, poor vision limit donning of stockings

— Solutions: stocking butlers/donning aids, zippered stockings, Velcro adjustable wraps (CircAid, Juxta-Lite)

— Caregiver/home health for compression bandage changes

— Screen for fall risk — multilayer bandages alter gait and shoe fit

— Polypharmacy review: amlodipine, gabapentin, NSAIDs worsen edema

— Simplify regimen, involve caregivers, written instructions

— Capacity assessment if patient refuses compression despite recurrent ulcers

— Avoid NSAIDs entirely

— Pentoxifylline: reduce dose if CrCl <30 mL/min

— ABI often falsely elevated (calcified vessels) — use toe-brachial index

— Differential broadens: calciphylaxis in ESRD patients with painful necrotic ulcers — very different management (no compression, sodium thiosulfate)

— Lower-extremity edema may reflect hypoalbuminemia/ascites — diuresis and albumin support

— Coagulopathy increases bleeding under compression — adjust pressure

— Acetaminophen dose limit ≤2 g/day if cirrhosis

— Optimize CHF first (diuretics, GDMT)

— Compression is safe and beneficial in compensated CHF; in decompensated CHF, sudden high compression can precipitate pulmonary edema by autotransfusion — start low and titrate up

Board pearl: In a dialysis patient with a painful, necrotic leg ulcer and violaceous mottling, think calciphylaxis, not VSU — biopsy shows calcified vessels; treat with sodium thiosulfate, not compression.

Step 3 management: For frail elders unable to don stockings, order Velcro adjustable compression wraps and arrange home health for bandage changes — adherence beats theoretical optimal pressure.

Elderly patients (the modal VSU patient):

Cognitive impairment:

Renal impairment:

Hepatic impairment:

Heart failure with edema:

Special Populations — Pregnancy and Other Demographic Subgroups

— Venous reflux worsens due to progesterone-mediated vein dilation, IVC compression, and volume expansion

— Active VSU in pregnancy is uncommon but varicose veins and edema are nearly universal in the third trimester

— Management: graduated compression stockings 20–30 mmHg are safe and recommended; leg elevation; avoid prolonged standing

— Defer endovenous ablation and sclerotherapy until postpartum (most reflux improves spontaneously after delivery)

— Pentoxifylline: pregnancy category C — avoid

— Screen for DVT with any unilateral leg swelling — pregnancy is a hypercoagulable state

— Malleolar ulcers from microvascular occlusion + venous insufficiency

— Hydroxyurea, transfusion optimization, compression with caution

— Pain control often requires opioids; involve hematology

— Phlebolymphedema → combined therapy with complete decongestive therapy (CDT): manual lymphatic drainage, multilayer bandaging, exercise, skin care

— Refer to certified lymphedema therapist

— Dependency syndrome with massive lower extremity edema; weight loss is the highest-impact intervention

— Bariatric surgery referral if appropriate

— Construction, retail, healthcare workers — counsel on compression at work, scheduled elevation breaks

— Document return-to-work limitations

Board pearl: Bilateral medial malleolar ulcers in a young Black patient with anemia → think sickle cell ulcers, not primary VSU; get hemoglobin electrophoresis.

Step 3 management: In pregnancy, prescribe 20–30 mmHg knee-high stockings at the first prenatal visit if varicosities or family history — primary prevention of pregnancy-related venous disease.

Pregnancy:

Pediatric/adolescent leg ulcers: VSU is rare — consider sickle cell disease, vasculitis, pyoderma gangrenosum, factitial, hereditary hemolytic anemias

Patients with sickle cell disease:

Lymphedema overlap (common in obese patients):

Obesity (BMI >40):

Occupational/social context:

Complications and Adverse Outcomes

— Cellulitis: unilateral expanding erythema, warmth, fever — treat with systemic antibiotics covering Staph/Strep

— Deep tissue infection / abscess: requires drainage, imaging if extensive

— Osteomyelitis: ulcer probing to bone, non-healing despite optimal care — MRI, bone biopsy, prolonged IV antibiotics

— Necrotizing fasciitis (rare but lethal): severe pain out of proportion, rapid spread, crepitus, systemic toxicity → surgical emergency

— Very common — sensitization to lanolin, neomycin, bacitracin, fragrances, rubber accelerators in dressings/wraps

— Patch testing if recurrent eczematous reactions

— Thin atrophic skin over a varicosity can rupture from minor trauma → brisk bleeding

— Management: elevate the leg above the heart, direct pressure — almost always controls bleeding; then definitive ablation

— Develops in chronic wounds (often >10–20 years) — aggressive, metastasizes early

— Biopsy any non-healing or atypical ulcer

— Chronic inflammation → fibrosis → restricted ankle motion → worsened calf pump dysfunction → vicious cycle

— Chronic pain, exudate, odor, social isolation, depression

— Substantial quality-of-life impact; screen with PHQ-9

— Up to 70% within 5 years without ongoing compression

— Strongest predictors: non-adherence to stockings, untreated reflux, obesity

Board pearl: Bleeding varicosity → elevate and apply pressure first; tourniquets and emergent surgery are wrong answers.

Key distinction: Rapidly spreading erythema with severe disproportionate pain in a chronic ulcer = necrotizing fasciitis until proven otherwise — surgical consultation, broad-spectrum antibiotics, do not delay for imaging.

Infection:

Contact dermatitis:

Hemorrhage from varicose veins:

Marjolin ulcer (SCC):

Lipodermatosclerosis and ankle ankylosis:

Psychosocial:

Recurrence:

When to Escalate Care — Consultations and Inpatient Triage

— Vascular surgery / vein specialist:

— Reflux or obstruction on duplex

— Non-healing despite 4–6 weeks of optimal compression

— Recurrent VSU

— Bleeding varicosities

— Wound care center / certified wound nurse:

— Complex wounds, multiple dressing failures

— Need for advanced modalities (skin substitutes, NPWT)

— Dermatology:

— Suspected contact dermatitis (patch testing)

— Atypical ulcer requiring biopsy

— Suspected pyoderma gangrenosum or vasculitis

— Lymphedema therapist (CLT): phlebolymphedema, severe edema

— Dietitian: nutritional optimization, weight loss

— Physical therapy: gait, calf pump training, donning aids

— Suspected DVT (unilateral acute swelling, calf pain)

— Cellulitis with systemic signs (fever, tachycardia, hypotension)

— Acute limb ischemia (cold, pulseless, painful — wrong limb!)

— Massive bleeding not controlled by elevation/pressure

— Sepsis from wound infection

— Necrotizing soft tissue infection — OR

— Osteomyelitis requiring IV antibiotics if outpatient OPAT not feasible

— Failure of outpatient management in frail patient who cannot self-care

— Septic shock, necrotizing fasciitis with hemodynamic instability

CCS pearl: For uncomplicated VSU, the entire case can be managed in the outpatient location — counsel patient, prescribe compression, order duplex, schedule 2-week follow-up. Move to ED only for sepsis or acute ischemia.

Step 3 management: Early vascular referral (within weeks, not months) is the new standard — EVRA-style intervention improves outcomes and is the right Step 3 answer for a VSU patient with documented saphenous reflux.

Outpatient referrals (the bread and butter of Step 3 VSU management):

Urgent/ED referral:

Inpatient admission:

ICU:

Key Differentials — Other Vascular and Lower Extremity Ulcers

— Location: toes, lateral malleolus, pressure points, distal foot

— Appearance: "punched-out," dry, pale base, well-demarcated borders

— Pain: severe, worse with elevation, improved by dependency

— Exam: absent pulses, cool, hairless, atrophic skin; ABI <0.9

— Treatment: revascularization first, do not apply compression to ABI <0.5

— ABI 0.5–0.8 → modified low compression (23 mmHg), address arterial disease

— Location: plantar surface, especially metatarsal heads, heels

— Painless, surrounded by callus

— Loss of protective sensation on monofilament testing

— Treatment: offloading (total contact cast), glycemic control, infection control

— Painful, irregular, often necrotic centers, palpable purpura

— Systemic symptoms: arthralgias, renal disease, neuropathy

— Workup: ANCA, ANA, cryoglobulins, complement, biopsy

— Rapidly enlarging painful ulcer with violaceous, undermined edges

— Pathergy — worsens with debridement (key Step 3 trap!)

— Associated with IBD, RA, hematologic malignancy

— Treatment: immunosuppression (steroids, cyclosporine, biologics), not debridement

— ESRD/dialysis, warfarin

— Painful retiform purpura → necrotic eschar, bilateral, proximal extremities

— Treatment: sodium thiosulfate, parathyroidectomy if indicated

Key distinction: Pain worse with elevation → arterial; pain worse with dependency → venous. Get this right on every stem.

Board pearl: A "non-healing leg ulcer that gets bigger every time we debride it" = pyoderma gangrenosum — stop debriding, start steroids, look for underlying IBD.

Arterial ulcers (PAD):

Mixed arterial-venous ulcers (15–20% of leg ulcers):

Diabetic neuropathic ulcers:

Vasculitic ulcers:

Pyoderma gangrenosum:

Calciphylaxis:

Key Differentials — Infectious, Neoplastic, and Other Causes

— Cellulitis: unilateral, acute, fever, leukocytosis, tender warm erythema

— Stasis dermatitis: bilateral, chronic, weeping/scaly, afebrile, normal WBC

— Misdiagnosis rate of bilateral lower extremity cellulitis is ~30% — most are stasis dermatitis

— Acute unilateral swelling, calf tenderness, Homans sign (unreliable)

— Wells score → D-dimer / duplex

— Can coexist with VSU — superimposed acute DVT presents as worsening edema or pain

— Chronic wound (often >10 years) → exuberant granulation, rolled edges, bleeding

— Biopsy edge of any chronic non-healing ulcer

— Mycobacterium marinum, M. ulcerans, sporotrichosis — exposure history (gardening, aquariums, travel)

— Tissue culture for AFB, fungi

— Geometric, accessible locations, inconsistent history, psychiatric comorbidities

— Patients on long-term hydroxyurea (CML, sickle cell, MPN) — malleolar ulcers

— Resolve with drug discontinuation

Board pearl: Bilateral lower extremity "cellulitis" is almost always stasis dermatitis — stop the antibiotics, start the steroid and compression.

Key distinction: Always biopsy a leg ulcer that fails to heal at 3 months despite optimal compression — Marjolin is rare but lethal if missed.

Cellulitis vs stasis dermatitis (the most tested pair):

DVT:

Squamous cell carcinoma (Marjolin ulcer):

Basal cell carcinoma, melanoma: pigmented lesions ulcerating

Cutaneous lymphoma: rare but mimics chronic ulceration

Mycobacterial / atypical infections:

Cutaneous leishmaniasis: travel to endemic areas, painless chronic ulcer

Factitial ulcer (dermatitis artefacta):

Hydroxyurea-induced ulcers:

Brown recluse / arthropod: necrotic central area, exposure history

Drug-induced edema mimicking venous disease: amlodipine, gabapentin, pioglitazone, NSAIDs

Secondary Prevention and Long-Term Plan

— Graduated knee-high stockings 30–40 mmHg after ulcer healing

— 20–30 mmHg if patient cannot tolerate higher pressure

— Replace every 3–6 months (elasticity decays)

— Apply in morning before getting out of bed; remove at bedtime

— Adherence at 5 years correlates directly with recurrence rates (97% non-adherent recur vs <30% adherent)

— Endovenous ablation of saphenous reflux reduces recurrence (EVRA, ESCHAR trials)

— Iliac stenting for obstruction in selected patients

— Weight loss to BMI <30

— Daily walking and calf exercises ("heel raises 10× hourly")

— Leg elevation 30 min, 3–4×/day

— Avoid prolonged standing/sitting; ankle pumps if immobile

— Skin care: daily emollient (white petrolatum, plain moisturizer); avoid fragrances and lanolin

— Discontinue or minimize edema-inducing drugs (amlodipine → ARB; pioglitazone → alternative)

— Continue pentoxifylline if it contributed to healing? Generally stop after healing

— Optimize diabetes, hypertension, CHF

— Daily skin inspection

— Early presentation for any new break in skin

— Compression non-negotiable

Step 3 management: The single best long-term prescription after a healed VSU is lifelong 30–40 mmHg graduated knee-high compression stockings, replaced every 6 months — this is the answer 9/10 times.

Board pearl: Switching amlodipine to an ARB can dramatically reduce leg edema and improve VSU recurrence — review the med list at every visit.

Compression for life is the cornerstone of recurrence prevention:

Address the underlying cause:

Lifestyle:

Discharge medication review after healed ulcer:

Vaccinations: tetanus current (last dose within 10 years), pneumococcal, influenza, COVID — relevant in chronic wound patients

Patient education materials and teach-back:

Insurance/value considerations: stockings often require physician documentation of medical necessity; durable medical equipment benefit varies

Follow-Up, Monitoring Parameters, and Counseling

— Active ulcer: every 1–2 weeks for wound assessment, compression reapplication, education

— Reduction in wound area of ≥40% by 4 weeks predicts healing — if not met, escalate (vascular referral, advanced dressings, biopsy)

— Once healed: monthly × 3, then every 3 months × 1 year, then every 6–12 months indefinitely

— Wound dimensions (length × width × depth), photograph

— Compression adherence, stocking condition (replace q3–6 months)

— Weight, BP, glycemic control (HbA1c q3 months if diabetic)

— Skin integrity in gaiter region, signs of dermatitis or early ulcer recurrence

— Pain (0–10 scale), function, mood (PHQ-2 → PHQ-9 prn)

— Demonstrate stocking application — donning aids if needed

— Trigger avoidance: trauma, prolonged standing/sitting, hot baths

— Skin care routine: gentle cleansing, daily emollient

— When to call: increasing pain, redness, drainage, fever, new ulcer

— Smoking cessation (impairs healing, worsens PAD risk)

— Nutrition: adequate protein (1.2–1.5 g/kg/day), vitamin C, zinc if deficient

— Calf-strengthening, ankle range-of-motion exercises

— Supervised walking program

— Aquatic therapy is excellent (hydrostatic pressure = natural compression)

— Detailed notes supporting medical necessity for stockings, wraps, home health

Step 3 management: If a VSU has not reduced in area by ≥40% at 4 weeks of optimal compression, that is the trigger for advanced therapy referral (vascular surgery, wound center, skin substitutes, biopsy).

Board pearl: Healing trajectory matters more than absolute size — a slowly-shrinking ulcer can be managed with continued compression; a stagnant or growing ulcer needs escalation and biopsy.

Follow-up cadence in primary care:

Monitoring parameters at each visit:

Counseling content:

Rehabilitation:

Documentation for DME and disability:

Ethical, Legal, and Patient Safety Considerations

— Discuss risks: skin breakdown under bandages, contact dermatitis, in PAD patients limb ischemia from over-compression

— Document ABI before ordering compression — applying high compression in undiagnosed PAD is a documented malpractice claim

— Many patients refuse stockings (uncomfortable, hot, hard to don, cosmetic)

— Respect autonomy, but document repeated counseling, alternatives offered (wraps, lower pressure), and risks of recurrence

— Capacity assessment if recurrent refusal jeopardizes health (rare); usually a shared-decision issue, not capacity

— Hospital discharge after cellulitis/DVT: ensure outpatient wound care follow-up scheduled within 1 week, compression resumed, vascular referral arranged

— Communicate wound size, dressing regimen, ABI, antibiotic course, and follow-up plan to receiving clinician

— Medication reconciliation — restart anticoagulants and antihypertensives appropriately

— Unusual ulcer locations, multiple injuries, inconsistent history → consider elder abuse or neglect; report per state law

— Pressure ulcers in dependent patients may indicate caregiver neglect

— Compression stockings cost $50–150/pair; insurance coverage variable

— Provide samples, prescribe alternatives (Velcro wraps) if unaffordable

— Language and literacy concerns — use teach-back, translated materials

— Photo documentation (with consent) supports clinical decisions and billing

— Wound clinic outcomes are increasingly tracked as quality metrics

Step 3 management: Always check ABI before prescribing compression — applying 40 mmHg compression to a patient with critical limb ischemia can cause limb loss; this is a sentinel safety event.

Board pearl: A patient who repeatedly declines stockings is not "non-compliant" — explore barriers (cost, donning difficulty, heat intolerance, body image) and offer adjustable wraps as an evidence-based alternative.

Informed consent for compression therapy:

Patient autonomy and non-adherence:

Transitions of care (a heavily tested Step 3 domain):

Mandatory reporting and abuse:

Health equity:

Documentation and quality:

High-Yield Associations and Rapid-Fire Clinical Facts

— >0.8 → full compression

— 0.5–0.8 → modified

— <0.5 → no compression, vascular referral

— >1.3 → use toe-brachial index

Board pearl: When in doubt: compression + duplex + ABI + pentoxifylline + vascular referral — this combination is the right answer for nearly every VSU vignette.

Step 3 management: Quality metrics that matter: time to healing, recurrence rate, stocking adherence, 40% area reduction at 4 weeks.

Most common location of VSU: medial malleolus / gaiter area

Cornerstone of therapy: graduated compression (30–40 mmHg)

Best adjunctive drug: pentoxifylline 400 mg TID

Mandatory test before compression: ABI

ABI cutoffs:

Confirmatory imaging for reflux: standing venous duplex ultrasound

EVRA trial: early endovenous ablation improves healing and reduces recurrence

Recurrence rate without compression: up to 70% in 5 years

Adherence-driven recurrence: <30% with consistent stocking use

Biopsy any ulcer present >3 months without healing → rule out Marjolin SCC

Bilateral "cellulitis" is usually stasis dermatitis

Pyoderma gangrenosum pathergy → avoid debridement

Calciphylaxis in dialysis patients → sodium thiosulfate

Sickle cell → malleolar ulcers, hydroxyurea may help underlying but can cause drug-induced ulcers

Most evidence-based adjunct after compression: pentoxifylline, then aspirin

Most evidence-based procedure: superficial venous ablation if reflux present

Skin substitutes (Apligraf, Dermagraft): consider for ulcers unhealed at 4 weeks

Wound bed: moist, debrided, infection-free; avoid wet-to-dry, peroxide, iodine, neomycin

Edema-worsening meds: amlodipine, gabapentin, pioglitazone, NSAIDs

Multilayer compression > single-layer; 4-layer (Profore) and Unna boot are workhorses

40% area reduction at 4 weeks predicts healing

Stockings replaced every 3–6 months

Lymphedema overlap → complete decongestive therapy

Patient self-care: elevation 30 min × 3–4/day, calf exercises, skin emollient

Board Question Stem Patterns

— Answer: Multilayer compression therapy (after confirming ABI)

— Answer: Refer for endovenous ablation (EVRA principle) and continue compression + pentoxifylline

— Answer: Stasis dermatitis — treat with medium-potency topical steroid + compression + emollient, not antibiotics

— Answer: Toe-brachial index

— Answer: Punch biopsy of the wound edge to rule out Marjolin ulcer (SCC)

— Answer: Calciphylaxis — sodium thiosulfate, stop warfarin, optimize calcium-phosphate-PTH

— Answer: Pyoderma gangrenosum — systemic corticosteroids

— Answer: Lifelong knee-high graduated compression stockings 30–40 mmHg, replaced every 6 months

— Answer: Leg elevation above heart level + direct pressure, not tourniquet

Board pearl: When the stem says "ABI 0.4 and a leg ulcer," do not pick compression — pick vascular surgery referral for revascularization.

Key distinction: Pain worse with elevation → arterial; pain worse with dependency → venous. The position-of-pain detail in the stem is your discriminator.

Stem 1: 58-year-old woman, BMI 33, varicose veins, shallow weeping ulcer over medial malleolus × 2 months, hemosiderin staining, dorsalis pedis pulses 2+, ABI 1.0. Next step?

Stem 2: Same patient, ulcer present 4 months despite compression, duplex shows great saphenous reflux 1.2 sec. Next step?

Stem 3: Bilateral erythematous, scaly, weeping plaques over lower legs, afebrile, normal WBC, in patient with edema and varicosities. Diagnosis?

Stem 4: Diabetic with calcified arteries, ABI 1.4, leg ulcer. Next test?

Stem 5: Patient with chronic leg ulcer × 15 years, recent change with rolled edges and exuberant granulation. Next step?

Stem 6: Dialysis patient with painful violaceous necrotic ulcers on bilateral thighs, on warfarin. Diagnosis and treatment?

Stem 7: Ulcer with violaceous undermined borders, worsens with debridement, history of ulcerative colitis. Diagnosis?

Stem 8: Healed VSU, asks what to do to prevent recurrence. Best answer?

Stem 9: Bleeding varicosity at the ankle, brisk hemorrhage. Initial step?

One-Line Recap

Venous stasis ulcers are managed in primary care with lifelong graduated compression (30–40 mmHg, after checking ABI), early vascular referral for treatable reflux, pentoxifylline as the best pharmacologic adjunct, wound bed optimization with moist non-toxic dressings, and aggressive comorbidity control — biopsy any ulcer unhealed at 3 months to rule out Marjolin SCC.

Step 3 management: The right outpatient flow for any VSU vignette is ABI → duplex → compression → pentoxifylline → vascular referral → 2-week follow-up → lifelong stockings after healing — memorize this sequence and you will answer nearly every Step 3 venous ulcer question correctly.

Board pearl: Compression heals VSUs; ablation prevents recurrence; biopsy catches the cancer; ABI keeps the limb. Miss any one of these and you miss the question.

Diagnose clinically: medial malleolar shallow ulcer + hemosiderin staining + edema + varicosities = VSU; always confirm hemodynamics with ABI and standing venous duplex.

Treat with the 4 C's: Compression (multilayer 35–40 mmHg, gold standard), Cleansing/wound prep (moist, debrided, non-toxic dressings), Correction of reflux (early endovenous ablation per EVRA), Comorbidity optimization (weight, glucose, edema-inducing drugs).

Prevent recurrence: lifelong knee-high graduated stockings 30–40 mmHg, replaced every 3–6 months — adherence is the single strongest predictor of staying ulcer-free, with recurrence dropping from ~70% to <30% in 5 years.

Know the mimics: bilateral "cellulitis" → stasis dermatitis; punched-out lateral malleolar ulcer with pain on elevation → arterial; non-healing ulcer >3 months → biopsy for Marjolin SCC; violaceous undermined edges worsening with debridement → pyoderma gangrenosum; dialysis patient with retiform necrosis → calciphylaxis.